Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid intravenous treatment with the amino acid arginine, experiencing no side effects from the treatment. In half of the stroke episodes, patients showed clinical improvements in symptoms such as seizures and partial paralysis.
Heart-attack sufferers who receive treatment during periods when interventional cardiologists are away at academic conferences are more likely to survive in the month after their heart attack than patients receiving treatment during nonmeeting days.
A simple dietary supplement (L-arginine) was found to improve birth outcomes, paving the way for future clinical trials to test this inexpensive and safe intervention.
One of the nation’s leading cardiologists is challenging the new hypertension guidelines, perhaps sparing up to 10 million people from unnecessarily aggressive blood pressure treatments. His team’s study results appear March 7 in the Journal of the American College of Cardiology.
UC San Diego Health is the first hospital in California to use the fifth generation troponin test to detect damage to the heart. The test was approved in the United States in 2017.
Julie Work always ate healthy and exercised regularly. Then, she passed out behind the wheel, went to a cardiologist and learned she needed a pacemaker. After recovery, she signed up for exercise boot camp and pushed herself to the limit. She needed to two pacemaker adjustments to keep up with her intense exercise regime.
A study of mouse healing after severe heart attacks focused on the heart and spleen, measuring types and numbers of immune cells; types and amounts of lipid signaling compounds; expression of enzymes that produce those signaling compounds; and which enzymes are key to resolution of inflammation.
SBP researchers have discovered that accumulation of ceramides—a type of lipid (fat)— plays a crucial role in lipotoxic cardiomyopathy (LCM)—a heart condition that often occurs in patients with diabetes and obesity. The study, published today in Cell Reports, also identified several potential therapeutic targets that could prevent or reverse the effects of LCM.
Giving birth to a child can be described as a sacred, spiritual and life-changing experience. It can also be fraught with pain, fear, complications and injury to both child and mother. For Dr. Steve Corns, associate professor of engineering management and systems engineering at Missouri University of Science and Technology, the key to removing some of the uncertainty associated with giving birth may lie not with woman or man, but with machine — machine learning, to be precise.
A study published in the March 5 online edition of the Proceedings of the National Academy of Sciences (PNAS) describes how the supercomputers at the San Diego Supercomputer Center at UC San Diego were used to simulate the merger of a G-protein “mimetic nanobody” to a G-protein-coupled receptor (GPCR), the largest and most diverse group of membrane receptors in animals, plants, fungi, and protozoa.
New research from the Endocrine Society and Avalere Health finds that clinicians lack the resources to identify, assess and manage patients who are at a high risk of developing hypoglycemia, or episodes of dangerously low blood sugar.
Physicians at Ohio State University are taking an innovative approach to improve care for patients receiving aortic valve replacements. They’re working alongside biomedical engineers from Ohio State’s College of Engineering, who have developed a way to model and predict potential complications so they can be avoided.
The first direct comparison of in vitro and in vivo screening techniques for identifying nanoparticles that may be used to transport therapeutic molecules into cells shows that testing in lab dishes isn’t much help in predicting which nanoparticles will successfully enter the cells of living animals.
Chest Pain Centers recognized for providing necessary care, resources to patients with heart attack symptoms.
A new study debunks the “obesity paradox,” a counterintuitive finding that showed people who have been diagnosed with cardiovascular disease live longer if they are overweight or obese compared with people who are normal weight at the time of diagnosis.
在美国心脏病学会（American College of Cardiology）第67届年度科学会议上发表的Mayo Clinic的一项研究表明，接受乳腺癌（breast cancer）或淋巴瘤（lymphoma）治疗的患者发生充血性心力衰竭（congestive heart failure）的可能性比未患癌症的患者高三倍。 在充血性心力衰竭中，心肌不再正常泵血。
A study published in the American Journal of Critical Care may help resolve the dilemma related to backrest elevation, finding that changing backrest elevation in critically ill patients receiving mechanical ventilation may not be as important or as effective in preventing pressure injuries as once thought.
Los pacientes con tratamiento previo para cáncer de mama o linfona tienen un riesgo tres veces mayor de sufrir insuficiencia cardíaca congestiva, que los pacientes sin cáncer. La insuficiencia cardíaca congestiva ocurre cuando el músculo cardíaco no bombea la sangre tan bien como debería.
Patients who were treated for breast cancer or lymphoma are more than three times at risk for developing congestive heart failure, compared with patients who did not have cancer. Congestive heart failure is when the heart muscle does not pump blood as well as it should. This research is being presented at the American College of Cardiology’s 67th Annual Scientific Session.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right